Nokia Oyj (0HAF)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 7.970 |
|---|---|
| 52-week range | 5.072 – 14.995 |
| Return, 1 month / 3 months | −13.2% / −1.4% |
| Return, 1 year / 3 years | +49.7% / +180.5% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 55.4% |
| Worst drawdown (1 year) | -49.9% |
| Average daily value traded | 41.73M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nokia Oyj is a Finnish technology and networking company based in Espoo. It supplies telecommunications operators and enterprises with mobile and fixed network infrastructure, including radio access equipment, core network systems and optical networks. Nokia also provides network software and services, and it licenses intellectual property from its research work. Its customers include telecom carriers, internet service providers, large enterprises and governments around the world, and the company also licenses its brand for consumer devices made by partner firms.
On this site Nokia Oyj appears as a stock on the London Stock Exchange (UK), code 0HAF, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nokia Oyj (0HAF) trades on the London Stock Exchange in UK. It last closed at EUR 7.970 on 27 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 2,472 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 49.7% and over the last three months it fell 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.8% | ||
| From 52-week high | -46.2% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.4% | ||
| 6-month return | -13.4% | ||
| 12-month return, skipping the last month | 72.6% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.9% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 41.73M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | −13.2% |
| 3 months | −1.4% |
| 6 months | −13.4% |
| 1 year | +49.7% |
| 3 years | +180.5% |
| 5 years | +79.9% |
Signals
| 50-day / 200-day average | 8.848 / 8.834 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.390 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jul 2026 | EUR 0.0400 |
| 27 Apr 2026 | EUR 0.0400 |
| 2 Feb 2026 | EUR 0.0300 |
| 27 Oct 2025 | EUR 0.0300 |
| 28 Jul 2025 | EUR 0.0400 |
| 2 May 2025 | EUR 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.